Discover and read the best of Twitter Threads about #twitterless
Most recents (4)
My first #dissertation chapter has been published! The paper focuses on #predation of #urban #wildlife by #cats with recommendations for collaborative data-driven management strategies. Main points are summarized in this #infographic, but more info and paper link in this thread! 
We spent 3 years surveying #WashingtonDC for #cats using #trailcams. Whenever we saw an image of a cat carrying prey, we noted the species and location, and added it to our predation database.
Bumping this again because it really does illustrate an important point about the nature of ideology. That is, ideology cannot be reduced to symbolic ideology - ideology as identity and the set of social & psychological motives that attract ppl to an ideological identity (1/n)
Rather, ideological labels and the motives behind them to some extent acquire different socially-constructed content on the basis of group/party conflicts, elite actions, and historical features unique to specific societies. (2/n)
In this regard, an especially interesting pattern in the above data is that right-wing identifiers in the US are different from their counterparts even in other English-speaking, Anglo-Saxon influenced nations, e.g., NZ, Australia, Canada. (3/n)
Inspired by @runthelistpod’s exceptional episode on “Starting Intern Year During a Pandemic,” here is my first attempt at a #tweetorial on the topic of GOC family meetings 1/18
Since @walkerreddmd & @emily_gutowski provided such a great discussion on the added challenges of having humanistic family meetings during the #COVID19 pandemic, let’s touch on some fundamentals 2/18
The following points are gleaned from an “ADLS (Advanced Disease Life Support) Interprofessional Primary Palliative Care” module by my mentor, role model, and friend, the #twitterless Dr. Tim Short @uvahealthnews 3/18
Round 2 of the Great ID Debates of #ASHP18 @ASHPOfficial comes to us from the brilliant minds of @SIDPharm members @TimbrookTT and @julie_justo. To start us off, Tristan makes the case for #fidaxomicin (FID) for treatment of Clostridioides difficile (#cdiff) infection
.@TimbrookTT sets up the major points for FID in the treatment of #Cdiff: 1- ⬇️recurrence compared to #vancomycin (VAN) in RCTs + ⬆️in cure without recurrence (aka global clinical cure) 2- this held up in real-world data 3- cost-effectiveness analyses support 1st line use #ASHP18
.@TimbrookTT notes the 2018 @IDSAInfo guidelines for #cdiff (idsociety.org/practice-guide…) recommend FID equally to VAN and for first recurrence, quality of evidence is higher 👀🤔#ASHP18
